12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 2d ago
Gainers
- Nektar Therapeutics (NASDAQ:NKTR) stock increased by 128.3% to $21.78 during Tuesday's regular session. The market value of their outstanding shares is at $118.3 million.
- OneMedNet (NASDAQ:ONMD) shares increased by 106.64% to $0.7. The company's market cap stands at $10.3 million.
- Eyenovia (NASDAQ:EYEN) shares rose 71.71% to $9.41. The market value of their outstanding shares is at $15.7 million.
- Amarin Corp (NASDAQ:AMRN) stock increased by 32.85% to $16.74. The market value of their outstanding shares is at $260.9 million.
- Trinity Biotech (NASDAQ:TRIB) shares increased by 29.29% to $0.71. The company's market cap stands at $10.5 million.
- Liminatus Pharma (NASDAQ:LIMN) shares rose 27.51% to $25.5. The company's market cap stands at $520.2 million.
Losers
- Impact BioMedical (AMEX:IBO) stock declined by 37.9% to $1.0 during Tuesday's regular session. The market value of their outstanding shares is at $19.4 million.
- Ernexa Therapeutics (NASDAQ:ERNA) stock decreased by 19.17% to $1.94. The company's market cap stands at $17.6 million.
- Soligenix (NASDAQ:SNGX) shares fell 18.49% to $1.34. The market value of their outstanding shares is at $5.3 million.
- NeOnc Technologies (NASDAQ:NTHI) shares fell 12.09% to $3.94. The market value of their outstanding shares is at $85.2 million.
- Indaptus Therapeutics (NASDAQ:INDP) stock fell 11.72% to $0.44. The company's market cap stands at $8.0 million.
- Adial Pharmaceuticals (NASDAQ:ADIL) shares fell 11.6% to $0.23. The company's market cap stands at $2.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.